Wednesday, July 8, 2026

biotech · Ataxia Telangiectasia · Ataxia Telangiectasia (A-T) · QNCX

Quince Therapeutics

News and analysis for Quince Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

South San Francisco, USA HQ
2012 Founded
21 Employees
Public company Type
QNCX · NYSE Ticker
Company details
Status
Public
HQ
South San Francisco, USA
Founded
2012
Employees
21
Programs
10
Drugs
8
Patents
1
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Quince Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Quince Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Quince Therapeutics yet.

Back to company overview →